We are live on ! Find out more
PA

Profund Advisors Portfolio holdings

AUM $2.72B
1-Year Est. Return 47.27%
This Fund
S&P 500
This Quarter Est. Return
+6.43%
1 Year Est. Return
+47.27%
3 Year Est. Return
+155.16%
5 Year Est. Return
+217.35%
10 Year Est. Return
+932.28%
AUM
$2.74B
AUM Growth
+$95.7M
Cap. Flow
+$25.4M
Cap. Flow %
0.93%
Top 10 Hldgs %
40.58%
Holding
1,201
New
69
Increased
381
Reduced
653
Closed
98

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$12.1M
2
AAPL icon
Apple
AAPL
+$11.2M
3
MSFT icon
Microsoft
MSFT
+$11M
4
PLTR icon
Palantir
PLTR
+$9.36M
5
GOOGL icon
Alphabet (Google) Class A
GOOGL
+$6.79M

Top Sells

Rank Stock Value
1
AVGO icon
Broadcom
AVGO
+$17.2M
2
META icon
Meta Platforms (Facebook)
META
+$9.54M
3
TSLA icon
Tesla
TSLA
+$2.9M
4
XOM icon
ExxonMobil
XOM
+$2.23M
5
CVX icon
Chevron
CVX
+$1.87M

Sector Composition

Rank Sector Weight
1 Technology 44.82%
2 Consumer Discretionary 12.21%
3 Communication Services 10.56%
4 Healthcare 9.72%
5 Financials 6.26%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
ODFL icon
126
Old Dominion Freight Line
ODFL
$48.5B
$3.2M 0.12%
18,134
+1,636
+10% +$333K
GEHC icon
127
GE HealthCare
GEHC
$27.6B
$3.18M 0.12%
40,706
+2,730
+7% +$232K
KHC icon
128
Kraft Heinz
KHC
$30.4B
$3.13M 0.11%
102,036
+7,302
+8% +$239K
IDXX icon
129
Idexx Laboratories
IDXX
$42.9B
$3.02M 0.11%
7,296
+487
+7% +$214K
SRE icon
130
Sempra
SRE
$60.8B
$3M 0.11%
34,214
-3,982
-10% -$348K
NBIX icon
131
Neurocrine Biosciences
NBIX
$17.7B
$2.97M 0.11%
21,723
-7,385
-25% -$913K
HDB icon
132
HDFC Bank
HDB
$119B
$2.84M 0.1%
89,078
-294
-0.3% -$9.4K
JD icon
133
JD.com
JD
$40.8B
$2.83M 0.1%
81,518
-10,970
-12% -$425K
TMO icon
134
Thermo Fisher Scientific
TMO
$211B
$2.8M 0.1%
5,385
-748
-12% -$411K
UTHR icon
135
United Therapeutics
UTHR
$26.3B
$2.79M 0.1%
7,908
-2,734
-26% -$1M
VZ icon
136
Verizon
VZ
$194B
$2.78M 0.1%
69,598
+15,098
+28% +$637K
ABT icon
137
Abbott
ABT
$180B
$2.76M 0.1%
24,414
-4,410
-15% -$510K
ANSS
138
DELISTED
Ansys
ANSS
$2.75M 0.1%
8,166
+440
+6% +$148K
BMRN icon
139
BioMarin Pharmaceuticals
BMRN
$11.5B
$2.74M 0.1%
41,706
-1,216
-3% -$81.5K
DXCM icon
140
DexCom
DXCM
$27.6B
$2.73M 0.1%
35,041
+1,922
+6% +$142K
WMB icon
141
Williams Companies
WMB
$90.5B
$2.68M 0.1%
49,591
-12,039
-20% -$649K
SRPT icon
142
Sarepta Therapeutics
SRPT
$1.66B
$2.68M 0.1%
22,017
-6,358
-22% -$779K
CCEP icon
143
Coca-Cola Europacific Partners
CCEP
$46.5B
$2.65M 0.1%
34,539
+3,814
+12% +$295K
CSGP icon
144
CoStar Group
CSGP
$11.3B
$2.65M 0.1%
37,053
-1,616
-4% -$122K
AEM icon
145
Agnico Eagle Mines
AEM
$72.6B
$2.62M 0.1%
33,482
-3,959
-11% -$326K
T icon
146
AT&T
T
$165B
$2.61M 0.1%
114,838
+22,640
+25% +$510K
EOG icon
147
EOG Resources
EOG
$78B
$2.61M 0.1%
21,314
-3,502
-14% -$447K
SLB icon
148
SLB Ltd
SLB
$77.8B
$2.61M 0.1%
67,957
-14,715
-18% -$618K
VST icon
149
Vistra
VST
$55.1B
$2.6M 0.1%
18,866
-1,396
-7% -$194K
MRNA icon
150
Moderna
MRNA
$21.5B
$2.59M 0.09%
62,248
-15,979
-20% -$764K

Similar funds

Profund Advisors's Q4 2024 Portfolio in Review

As of Q4 2024, Profund Advisors held 1,201 positions worth $2.74B, up 3.6% from $2.64B the previous quarter. Its ten largest holdings account for 41% of the portfolio.

Profund Advisors's Q4 2024 filing shows 69 new, 381 increased, 653 reduced and 98 closed positions. Its largest new stake was Applovin: 22,405 shares worth $7.26M. The largest sale was Broadcom, an estimated $17.2M.

By sector, the portfolio is most concentrated in Technology at 45% of assets, up from 43% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • Profund Advisors's largest Q4 2024 buy was Applovin: 22,405 shares worth $7.26M.
  • Profund Advisors added most to Amazon in Q4 2024, an estimated $12.1M increase.
  • Profund Advisors's biggest Q4 2024 reduction was Broadcom, cutting an estimated $17.2M.
  • Profund Advisors fully exited Dollar Tree in Q4 2024, selling an estimated $1.23M.
  • Profund Advisors's ten largest holdings make up 41% of its $2.74B portfolio in Q4 2024.
  • Profund Advisors opened 69 new positions and closed 98 in Q4 2024.
  • Profund Advisors's portfolio value rose 3.6% quarter-over-quarter to $2.74B.

Based on Profund Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.